| Latest Senesco Tech News Headlines | | Date | Time | Source | | | 09/29/2008 | 8:00AM | PRNUS | Senesco Technologies Reports Fiscal Year 2008 Financial Results
NEW BRUNSWICK, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today reported financial results for the fiscal year ended June 30, 2008 ("Fiscal 2008").
Net loss for Fiscal 2008 was $4.6 million, or $0.26 per share, compared with a net loss of $3.3 million... More...>> |
| 09/03/2008 | 8:00AM | PRNUS | Senesco Technologies to Present at BioPharm America(TM) 2008
NEW BRUNSWICK, N.J., Sept. 3 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today announced that the Company will be presenting at BioPharm America(TM) 2008. The conference is being held at the Grand Hyatt Hotel Atlanta in Buckhead, GA from September 9-10, 2008. Bruce... More...>> |
| 08/01/2008 | 8:00AM | PRNUS | Senesco Technologies Announces Successful Completion of First Milestone Related to Agreement with Bayer CropScience
NEW BRUNSWICK, N.J., Aug. 1 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today that Bayer CropScience has successfully completed the first R&D milestone related to Bayer's use of Senesco's technology in Brassica oilseeds.
Senesco's proprietary gene technology... More...>> |
| 07/07/2008 | 8:00AM | PRNUS | Senesco Technologies Closes Remaining $3.0 Million of Previously Announced Financing
NEW BRUNSWICK, N.J., July 7 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today announced that the Company recently closed on the remaining $3.0 million of its previously announced private placements with YA Global Investments, LP ("YA Global") and Stanford Venture Capital... More...>> |
| 07/03/2008 | 8:15AM | PRNUS | Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System
NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today that it has contracted with Polyplus-transfection (Illkirch, France) to supply Polyplus's "in vivo-jetPEI" for systemic delivery of Senesco's combination therapy of siRNA against Factor... More...>> |
| 07/03/2008 | 8:00AM | PRNUS | Senesco Chooses VGXI to Produce Factor 5A Plasmid
NEW BRUNSWICK, N.J., July 3 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today that it has contracted with VGXI, Inc. (The Woodlands, TX) ("VGXI") to supply the plasmid portion of the Company's combination therapy consisting of the Factor 5A gene and siRNA against... More...>> |
| 06/12/2008 | 8:00AM | PRNUS | Senesco Technologies to Present at BIO 2008 Business Forum
NEW BRUNSWICK, N.J., June 12 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today announced that the Company will be presenting at the Business Forum during BIO 2008, the Biotechnology Industry Organization's Annual International Convention, which is being held at the San... More...>> |
| 06/05/2008 | 8:37AM | PRNUS | Senesco Expands on Preclinical Multiple Myeloma Findings
NEW BRUNSWICK, N.J., June 5 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today further details of its continuing preclinical multiple myeloma research. In February 2008, the Company announced results of preclinical animal studies in which Senesco's Factor 5A... More...>> |
| 05/16/2008 | 9:08AM | PRNUS | Senesco Technologies Reports Third Quarter Fiscal 2008 Financial Results
NEW BRUNSWICK, N.J., May 16 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today reported financial results for the three months ended March 31, 2008.
Net loss for the three month period ended March 31, 2008 was $2.0 million, or $0.12 per share, compared with a net loss... More...>> |
| 04/15/2008 | 8:00AM | PRNUS | Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
NEW BRUNSWICK, N.J., April 15 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today further details of Dr. Raghavendra Mirmira's preclinical pancreatic islet cell research that was funded by the Company. Using a small interfering RNA (siRNA) against Senesco's Factor... More...>> |
| 04/02/2008 | 8:00AM | PRNUS | Senesco's Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
NEW BRUNSWICK, N.J., April 2, 2008 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today that Dr. Raghavendra Mirmira, one of the Company's funded researchers, will be presenting his findings regarding preclinical pancreatic islet cell data at two conferences in... More...>> |
| 03/25/2008 | 8:00AM | PRNUS | Senesco Technologies Regains Compliance With Amex's Continued Listing Requirements
NEW BRUNSWICK, N.J., March 25 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. (the "Company") (AMEX:SNT), today announced receipt of a notice from the American Stock Exchange ("AMEX") stating that the Company has resolved the continued listing deficiencies referenced in the AMEX's letters dated June 15, 2007 and... More...>> |
| 02/15/2008 | 8:00AM | PRNUS | Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
NEW BRUNSWICK, N.J., Feb. 15 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today reported financial results for the three months ended December 31, 2007.
Net loss for the three month period ended December 31, 2007 was $1.3 million, or $0.07 per share, compared with a net... More...>> |
| 02/06/2008 | 8:00AM | PRNUS | Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
NEW BRUNSWICK, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today the results of preclinical animal studies focused on multiple myeloma that were conducted concurrently at Mayo Clinic and the University of Waterloo. The goal of these studies, which... More...>> |
| 12/21/2007 | 9:00AM | PRNUS | Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
NEW BRUNSWICK, N.J., December 21 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today announced that the Company recently closed on an additional $4.0 million of its previously announced private placements with YA Global Investments, LP ("YA Global") and Stanford Venture... More...>> |
| 12/05/2007 | 7:00AM | PRNUS | Senesco Technologies Initiates Preclinical Studies for Cancer Target
NEW BRUNSWICK, N.J., Dec. 5 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) announced today, that it has initiated preclinical lab studies at Mayo Clinic focused on multiple myeloma. These studies will further test the ability of Senesco's Factor 5A gene technology to up-regulate... More...>> |
| 11/15/2007 | 8:00AM | PRNUS | Senesco Technologies Reports First Quarter Fiscal 2008 Financial Results
NEW BRUNSWICK, N.J., Nov. 15 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. ("Senesco" or the "Company") (AMEX:SNT) today reported financial results for the three months ended September 30, 2007.
Net loss for the three month period ended September 30, 2007 was $382,046, or $0.02 per share, compared with a net... More...>> |
| 11/01/2007 | 4:05PM | PRNUS | CORRECTION: Senesco Technologies Update Notice from AMEX on Non Compliance
NEW BRUNSWICK, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Senesco Technologies, Inc. (the "Company") (AMEX:SNT), today issued a correction to its October 30, 2007 press release entitled "Senesco Technologies Update Notice from AMEX on Non-Compliance." The Company's October 30, 2007 press release incorrectly stated that... More...>> |
|